https://www.ibnsina-pharma.com/investors/ibnsina-pharma-sustainability-report-2025/2026-05-03T12:12:30+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-fy2025/2026-05-03T12:10:50+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-3q2025/2026-05-03T12:09:56+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-1q2025/2026-05-03T12:08:54+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-fy2024/2026-05-03T12:07:54+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-3q2024/2026-05-03T12:06:34+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-2q2024/2026-05-03T12:05:32+00:00https://www.ibnsina-pharma.com/investors/disclosure-to-egx-regarding-haram-building-evaluation/2026-05-03T12:00:10+00:00https://www.ibnsina-pharma.com/investors/disclosure-to-egx-regarding-haram/2026-05-03T11:59:05+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-disclosure-form-for-the-bod-the-shareholders-structure-3/2026-05-03T11:58:06+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-disclosure-form-for-the-bod-the-shareholders-structure-2/2026-05-03T11:56:04+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-releases-audited-fy25-results/2026-05-03T11:52:48+00:00https://www.ibnsina-pharma.com/investors/ebrd-ushers-in-greener-era-for-ibnisna-pharma/2026-05-03T11:51:53+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-announces-the-sale-of-the-medical-building-and-its-administrative-annex-located-in-the-fifth-settlement-for-92-million-egyptian-pounds/2026-05-03T11:50:53+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-releases-audited-1h25-results/2026-05-03T11:49:34+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-announces-board-approval-of-appraiser-reports-for-the-haram-building/2026-05-03T11:48:37+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-announces-board-approval-of-appraiser-reports-for-the-land-building-and-machines-of-shorouk-specialized-hospital/2026-05-03T11:47:41+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-ranked-first-among-pharmaceutical-distribution-companies-in-egypt-in-2024-according-to-iqvia/2026-05-03T11:46:51+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-partners-with-yanmu-and-hassan-allam-utilities/2026-05-03T11:46:00+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-and-stryve-sign-a-cooperation-protocol-to-allow-credit-facilities-and-cash-back-to-lbnsina-pharma-clients/2026-05-03T11:44:57+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-4q25-standalone-financial-statements/2026-05-03T11:38:34+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-4q25-earnings-release/2026-05-03T11:33:44+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-3q25-earnings-release/2026-05-03T11:33:11+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-2q25-earnings-release/2026-05-03T11:32:37+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1q25-earnings-release/2026-05-03T11:32:00+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy24-earnings-release/2026-05-03T11:26:29+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-3q24-earnings-release/2026-05-03T11:25:41+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-2q24-earnings-release/2026-05-03T11:25:06+00:00https://www.ibnsina-pharma.com/investors/disclosure-form-regarding-the-board-of-directors-and-shareholder-structure/2026-05-03T10:37:21+00:00https://www.ibnsina-pharma.com/investors/bod-resolutions-on-01-03-2026/2026-05-03T10:33:41+00:00https://www.ibnsina-pharma.com/investors/bod-resolutions-on-13-11-2025/2026-05-03T10:33:07+00:00https://www.ibnsina-pharma.com/investors/bod-resolutions-on-12-08-2025/2026-05-03T10:32:37+00:00https://www.ibnsina-pharma.com/investors/bod-resolutions-on-27-05-2025/2026-05-03T10:31:57+00:00https://www.ibnsina-pharma.com/investors/bod-resolutions-on-24-02-2025/2026-05-03T10:31:11+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-tcfd-report-2025/2026-05-03T10:25:36+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-esg-report-2025/2026-05-03T10:24:59+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy25-board-of-directors-report/2026-05-03T10:24:13+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-tcfd-report-2024/2026-05-03T10:23:30+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-esg-report-2024/2026-05-03T10:22:18+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy24-board-of-directors-report/2026-05-03T10:21:14+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-4q25-consolidated-financial-statements/2026-04-19T09:59:03+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1q24-earnings-release-q1-2024/2024-07-17T12:51:53+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-ogm-decisions-28-march-2024/2024-07-21T13:59:03+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-q1-2024/2024-07-17T14:05:10+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-esg-report-2023/2024-07-18T13:00:50+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-tcfd-report-2023/2024-07-18T13:04:18+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-egm-minutes-30-july-2023/2024-07-21T13:52:38+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-agm-resolutions-2-april-2018/2024-07-21T13:50:28+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-q4-2023/2024-07-17T14:01:56+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-welcomes-dr-sahar-nasr-former-investment-and-international-cooperation-minister-as-independent-board-member/2024-07-17T13:46:26+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-q3-2023/2024-07-17T13:56:00+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-earnings-call-presentation-2q2023-q2-2023/2024-07-17T13:53:42+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1q24-consolidated-financial-statements/2024-07-17T13:41:16+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1q24-standalone-financial-statements/2024-07-17T13:39:04+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy23-consolidated-financial-statements/2024-07-17T13:34:39+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy23-standalone-financial-statements/2024-07-17T12:58:55+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy23-earnings-release-q4-2023/2024-07-17T12:44:29+00:00https://www.ibnsina-pharma.com/investors/disclosure-to-egx-regarding-ibnsina-bod-meeting/2024-02-14T10:41:38+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-sustainability-report-q2-2023/2024-02-15T10:20:41+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-q4-2022/2024-02-15T08:53:38+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-q3-2022/2024-02-15T08:58:09+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-q4-2020/2024-02-15T09:13:19+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-q3-2020/2024-02-15T09:19:06+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-q2-2020/2024-02-15T09:22:21+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-q4-2019/2024-02-15T09:27:49+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-q3-2019/2024-02-15T09:34:26+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-q2-2019/2024-02-15T09:38:19+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-q1-2019/2024-02-15T09:45:28+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-q4-2018/2024-02-15T09:49:46+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-q3-2018/2024-02-15T09:52:31+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-q2-2018/2024-02-15T10:02:35+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-q1-2018/2024-02-15T10:07:55+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-q4-2017/2024-02-15T10:10:59+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-investor-presentation-q3-2017/2024-02-15T10:15:27+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-3q23-consolidated-financial-statements/2024-02-12T14:01:17+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-is-at-the-forefront-of-drug-distribution-companies/2024-02-13T13:55:39+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-signed-three-medical-promotion-contracts-for-the-first-time/2024-02-13T13:58:20+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-issues-first-sustainability-report/2024-02-13T14:43:46+00:00https://www.ibnsina-pharma.com/investors/boehringer-ingelheim-and-ibnsina-pharma-sign-distribution-agreement-in-egypt/2024-02-13T14:52:29+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-and-sandoz-egypt-pharma-ink-strategic-partnership-to-improve-patient-access-to-otc-products/2024-02-14T09:12:55+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-and-omron-healthcare-sign-an-importation-distribution-agreement-in-egypt/2024-02-14T09:16:08+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-taps-into-the-hospital-business-with-the-acquisition-of-el-shorouk-hospital-at-el-shorouk-city/2024-02-14T10:16:25+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-turns-to-solar-power-for-sustainable-and-affordable-energy/2024-02-14T10:21:34+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-disclosure-form-for-the-bod-the-shareholders-structure/2024-02-14T12:59:09+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-organization-structure-and-data-modification-form/2024-02-14T13:03:36+00:00https://www.ibnsina-pharma.com/investors/release-from-ibnsina-pharma-isph-ca/2024-02-14T13:06:23+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-isph-ca-disclosure-form-for-the-bod-the-shareholders-structure/2024-02-14T13:09:39+00:00https://www.ibnsina-pharma.com/investors/release-from-ibnsina-pharma-isph-ca-2/2024-02-14T13:14:59+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-3q23-standalone-financial-statements-2023/2024-02-12T14:05:58+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-2q23-financial-statements/2024-02-12T14:11:49+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1q23-financial-statements/2024-02-12T14:19:08+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy22-financial-statements/2024-02-12T15:00:12+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-3q22-financial-statements/2024-02-13T09:39:52+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-2q22-financial-statements/2024-02-13T10:08:17+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1q22-financial-statements/2024-02-13T10:12:40+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy21-financial-statements/2024-02-13T11:17:31+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-2q21-financial-statements/2024-02-13T11:48:13+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy20-financial-statements/2024-02-13T11:56:02+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-3q20-financial-statements/2024-02-13T11:59:43+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-2q20-financial-statements/2024-02-13T12:21:30+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1q20-financial-statements/2024-02-13T12:23:57+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy19-financial-statements/2024-02-13T12:31:43+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-3q19-financial-statements/2024-02-13T12:37:12+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-2q19-financial-statements/2024-02-13T12:41:53+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1q19-financial-statements/2024-02-13T12:47:28+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy18-financial-statements/2024-02-13T12:51:18+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-3q18-financial-statements/2024-02-13T12:59:38+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-2q18-financial-statements/2024-02-13T13:01:48+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1q18-financial-statements/2024-02-13T13:05:25+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy17-financial-statements/2024-02-13T13:10:41+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy16-financial-statements/2024-02-13T13:14:27+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy15-financial-statements/2024-02-13T13:18:09+00:00https://www.ibnsina-pharma.com/investors/bnsina-pharma-9m23-earnings-release-q3-2023/2024-02-08T12:15:42+00:00https://www.ibnsina-pharma.com/investors/833/2024-02-08T12:20:52+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1q23-earnings-release-q1-2023/2024-02-08T12:24:17+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy22-earnings-release-q4-2022/2024-02-08T12:31:51+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-9m22-earnings-releaseq3-2022/2024-02-08T12:40:39+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1h22-earnings-release-q2-2022/2024-02-08T12:46:11+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1q22-earnings-release-q1-2022/2024-02-08T13:20:43+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy21-earnings-release-q4-2021/2024-02-08T13:31:43+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-9m21-earnings-releaseq3-2021/2024-02-08T13:37:42+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1h21-earnings-releaseq2-2021/2024-02-08T13:43:25+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1q21-earnings-release-q1-2021/2024-02-11T11:12:33+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy20-earnings-release-q4-2020/2024-02-11T11:18:29+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-9m20-earnings-releaseq3-2020/2024-02-11T11:23:07+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1h20-earnings-releaseq2-2020/2024-02-11T11:50:34+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1q20-earnings-releaseq1-2020/2024-02-11T11:54:25+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy19-earnings-release-q4-2019/2024-02-12T12:45:30+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-9m19-earnings-releaseq3-2019/2024-02-12T12:50:13+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1h19-earnings-release-q2-2019/2024-02-12T12:52:48+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1q19-earnings-release-q1-2019/2024-02-12T12:55:53+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy18-earnings-release-q4-2018/2024-02-12T12:59:35+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-3q18-earnings-release-q3-2018/2024-02-12T13:04:42+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1h18-earnings-release-q2-2018/2024-02-08T11:57:58+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-1q18-earnings-release-q1-2018/2024-02-08T11:53:35+00:00https://www.ibnsina-pharma.com/investors/research-coverage/2023-10-11T14:32:07+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy17-earnings-release/2024-02-08T11:55:45+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy17-board-of-directors/2023-09-23T18:56:47+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy19-board-of-directors-report/2023-09-23T18:56:25+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy17-board/2023-09-23T18:55:58+00:00https://www.ibnsina-pharma.com/investors/ibnsina-pharma-fy17-board-of-directors-report/2023-09-23T18:55:33+00:00